QCG
KROS icon

Quadrant Capital Group’s Keros Therapeutics KROS Stock Holding History

Quadrant Capital Group’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6
Closed -$242 – 2735
2023
Q2 		$242 Buy
+6
New +$242 ﹤0.01% 2643